The dual HDAC and PI3K inhibitor, CUDC‑907, inhibits tumor growth and stem‑like properties by suppressing PTX3 in neuroblastoma.

MLA

Li, Mengzhen, et al. “The Dual HDAC and PI3K Inhibitor, CUDC‑907, Inhibits Tumor Growth and Stem‑like Properties by Suppressing PTX3 in Neuroblastoma.” International Journal of Oncology, vol. 64, no. 2, Feb. 2024. EBSCOhost, https://doi.org/10.3892/ijo.2023.5602.

APA

Li, M., Hu, Y., Wang, J., Xu, Y., Hong, Y., Zhang, L., Luo, Q., Zhen, Z., Lu, S., Huang, J., Zhu, J., Zhang, Y., Que, Y., & Sun, F. (2024). The dual HDAC and PI3K inhibitor, CUDC‑907, inhibits tumor growth and stem‑like properties by suppressing PTX3 in neuroblastoma. International Journal of Oncology, 64(2). https://doi.org/10.3892/ijo.2023.5602

Chicago

Li, Mengzhen, Yang Hu, Juan Wang, Yanjie Xu, Ye Hong, Li Zhang, Qiuyun Luo, et al. 2024. “The Dual HDAC and PI3K Inhibitor, CUDC‑907, Inhibits Tumor Growth and Stem‑like Properties by Suppressing PTX3 in Neuroblastoma.” International Journal of Oncology 64 (2). doi:10.3892/ijo.2023.5602.